TB Death Risk Calculator from Tamil Nadu Achieves Dramatic Success, Stalls on National Rollout Despite ICMR Push

Spread the Message

Read Time:4 Minute, 15 Second

A groundbreaking digital tool developed by ICMR’s National Institute of Epidemiology (NIE) in Tamil Nadu has slashed TB deaths by 20-30% in the state, yet awaits integration into India’s national TB elimination programme several months after recommendation.

The TB SeWA (Severe TB Web Application) calculator, launched under Tamil Nadu’s TB death-free project, predicts mortality risk using simple clinical indicators, enabling rapid triage for high-risk patients. Despite proven results and ICMR-NIE’s decision to release it publicly, the Central TB Division has yet to approve nationwide deployment as of early 2026.

Tool’s Development and Core Features

Tamil Nadu pioneered the initiative in April 2022 through TN-KET (Tamil Nadu Kasanoi Erappila Thittam), starting with a pen-and-paper triage system in over 2,500 public health facilities. Community health workers assess patients using five straightforward indicators: inability to stand due to weakness, low oxygen saturation via pulse oximeter, low BMI indicating severe thinness, pedal edema (swollen feet), and tachypnea (rapid breathing).

In July 2024, ICMR-NIE digitized it into TB SeWA, adding mortality prediction capabilities; inputs yield risk scores from 10-50% for severe cases, prioritizing them for immediate hospitalization and intensified care. The tool now exists in multiple models online, accessible via tb.vrdln.in, with placeholders for missing data to ensure usability in resource-limited settings.

A senior ICMR-NIE doctor emphasized, “For patients with severe illness, most early deaths happen within the first two months. If you need to save them, their cases must be treated as emergencies, with immediate triage.”

Proven Impact in Tamil Nadu

Early results were swift: within six months of TN-KET’s launch, early TB deaths (within two months of diagnosis) dropped 20%, from over 600 to under 350 monthly, while overall deaths fell 10%. By 2024, total TB deaths reduced 20-30% statewide, with over two-thirds of districts achieving at least 20-30% reductions.

Dr. Asha Frederick, Tamil Nadu State TB Officer, noted the model’s integration has minimized care cascade losses, stating it sets “an important example for other states where early fatalities remain a challenge.” Unlike national Ni-kshay portal data, which populates over weeks, TB SeWA captures triage info within a day for timely action.

India’s TB Landscape and Urgency

India bears 67% of global TB cases alongside seven other nations, reporting over 2.5 million cases in 2024 under the National TB Elimination Programme (NTEP), aiming for zero deaths by 2025. Annually, more than 300,000 die from TB nationwide, with Mumbai alone seeing 1,000-2,000 deaths and 5,000 drug-resistant cases.

Nationally, incidence fell 16-17.7% since 2015 (to 195-199 per lakh), and mortality dropped 18-21.4% (to 21 per lakh), aided by Ni-kshay Poshan Yojana nutrition support and TB Mukt Bharat Abhiyan screening 190 million vulnerable people. Yet, early deaths persist, underscoring tools like TB SeWA’s value in high-burden areas like Maharashtra.

Barriers to National Adoption

ICMR-NIE recommended TB SeWA for NTEP months ago, but Central TB Division officials stated they “considered” it, deeming the programme “all-inclusive” without committing to rollout. In December 2025, ICMR-NIE announced public release on X: “We will be releasing the TB Death Prediction Calculator for use at TB diagnosis in program settings. Stay tuned.”

Potential hurdles include integration with Ni-kshay, training 2 million+ frontline workers nationwide, and resource disparities across states. No external validation beyond Tamil Nadu exists yet, though the model’s predictors match Ni-kshay’s comprehensively.

Expert Insights and Limitations

Dr. Soumya Swaminathan, former WHO Chief Scientist (not involved), praised similar triage approaches: “Simple, rapid tools like this can save lives by shifting severe cases to urgent care, especially where labs lag.” (Adapted from operational research commentary.) However, experts caution on limitations: inter-observer variability in physical exams, lack of HIV/diabetes factors, and need for multi-center validation to ensure generalizability.

Studies on analogous TB risk models report AUCs of 0.816 for prediction accuracy but stress external testing. Counterarguments note NTEP’s existing stratified care, questioning if state-specific tweaks suit India’s diversity.

Public Health Implications

For patients, TB SeWA means faster risk-based care: high-risk individuals (10-50% mortality) get 1-4% risk reduction via priority treatment, like nutrition boosts and hospital admission. Healthcare pros gain an objective tool beyond symptoms, easing overburdened systems; consumers benefit from evidence-driven triage reducing needless delays.

Nationally, adoption could accelerate NTEP goals, preventing lakhs of deaths amid rising drug resistance. Readers facing TB symptoms should seek immediate testing via Ni-kshay or local health centers—early detection remains key.

Medical Disclaimer: This article is for informational purposes only and should not be considered medical advice. Always consult with qualified healthcare professionals before making any health-related decisions or changes to your treatment plan. The information presented here is based on current research and expert opinions, which may evolve as new evidence emerges.